RT Journal Article
SR Electronic
T1 Dementia Risk Analysis Using Temporal Event Modeling on a Large Real-World Dataset
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.24.23287651
DO 10.1101/2023.03.24.23287651
A1 Taylor, Richard Andrew
A1 Gilson, Aidan
A1 Chi, Ling
A1 Haimovich, Adrian D.
A1 Crawford, Anna
A1 Brandt, Cynthia
A1 Magidson, Phillip
A1 Lai, James
A1 Levin, Scott
A1 Mecca, Adam P.
A1 Hwang, Ula
YR 2023
UL http://medrxiv.org/content/early/2023/03/25/2023.03.24.23287651.abstract
AB The objective of the study is to identify healthcare events leading to a diagnosis of dementia from a large real-world dataset. This study uses a data-driven approach to identify temporally ordered pairs and trajectories of healthcare codes in the electronic health record (EHR). This allows for discovery of novel temporal risk factors leading to an outcome of interest that may not otherwise be obvious. We identified several known (Down syndrome RR: 116.1, thiamine deficiency RR: 76.1, and Parkinson’s disease RR: 41.1) and unknown (Brief psychotic disorder RR: 68.6, Toxic effect of metals RR: 40.4, and Schizoaffective disorders RR: 40.0) factors for a specific dementia diagnosis. The associations with the greatest risk for any dementia diagnosis were found to be primarily related to mental health (Brief psychotic disorder RR: 266.5, Dissociative and conversion disorders RR: 169.8), or neurologic conditions or procedures (Dystonia RR: 121.9, Lumbar Puncture RR: 119.0). Trajectory and clustering analysis identified factors related to cerebrovascular disorders, as well as diagnoses which increase the risk of toxic imbalances. The results of this study have the ability to provide valuable insights into potential patient progression towards dementia and improve recognition of patients at risk for developing dementia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis publication was made possible by the Yale School of Medicine Fellowship for Medical Student Research. Research reported in this publication was supported by a Johns Hopkins University a2 Round 1 Pilot award from the National Institute on Aging (P30AG073104), the National Institute of Diabetes And Digestive And Kidney Diseases of the National Institutes of Health under Award Number T35DK104689, and National Institute on Aging (P30AG066508). ADH is supported by NIH KL2TR002542. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Yale University (IRB Registration #: 00011725) gave ethical approval for this work,I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors